|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 29, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD), a company whose stock has recently set a new 52-week high after tripling in price on the prospects of recently-realized and some still-developing catalysts, may have positioned itself - through its key partnerships and growing distribution channels - as a leader in the US to meet the growing demand for medical isotopes. Additionally, the recent acquisition of a key license to an exclusive technology may have also positioned the company to usher in the next generation of such technology.
VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, views the company as a potential big player in the future of the growing medical isotope industry, especially as AMIC brings in new technologies and patents to develop the 'treatments of the future.'
For a full update provided by VFC's Stock House on the company, visit: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-making-a-move-in-nuclear-medicine
As described by Dr. Alan Walter, Chair of the Scientific Committee, in a presentation published on the company's home page, Advanced Medical is developing its proprietary technology to create what he terms as "smart bullets" - meaning isotopes that target only cancerous cells, while leaving healthy cells unharmed. This technology is a step beyond and preferable to the currently-standing chemotherapy and radiation treatments that help to target cancerous cells, but also damage the healthy tissue.
An April acquisition demonstrates AMIC's progress along these lines as the company, at that time, acquired a license and eight patents relating to an injectible radiogel technology that can deliver Yttrium-90 "microspheres" directly into cancerous tissue. Yttrium-90 is an already-established medical isotope with numerous applications in cancer treatment, but its application in the radiogel holds significant advantages over current treatments, especially because the radiogel allows only a minimal amount of radiation to escape, thereby causing little - if any - damage to healthy tissue. In essence, this is the comparison to the "smart bullet" described by Dr. Walter. That noted benefit could quickly enable the product to steal market share from the current standard, should it gain acceptance into the community.
The ADMD share price started move after the announcement of this deal, most likely because the company now had another angle at which to attack a lucrative market already loaded with potential. Shares have settled in a tight range since, however, and are trading at a very attractive market cap, considering the potential of the technology on hand. Also adding to the drop from the highs could have been a mid-August 8k filing announcing the granting of three million shares that became fully-vested at the time of issuance.
That said, with a solid management and scientific team at the helm and numerous technologies and business growth strategies with which to attack the market, ADMD could have the makings of a nice, speculative growth story for investors willing to take the small-cap risk that always accompanies the small-cap reward potential.
The foundations for success are well in place, the portfolio is stocked with currently-distributed products, and emerging technologies could take AMIC to the next level.
Follow ADMD developments at VFCsStockHouse.com
Contact VFC's Stock House: vfc@vfcsstockhouse.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
